Volume 59, Issue 3, Pages e7-e8 (March 2011)

Slides:

Advertisements

Similar presentations

Volume 58, Issue 5, Pages (November 2010)

Advertisements

The PSA Era is not Over for Prostate Cancer

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

European Urology Focus

Volume 63, Issue 2, Pages (February 2013)

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Volume 69, Issue 1, Pages (January 2016)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 63, Issue 3, Pages e39-e40 (March 2013)

Volume 54, Issue 4, Pages (October 2008)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 73, Issue 5, Pages (May 2018)

Volume 64, Issue 3, Pages (September 2013)

Prostate Cancer Epidemic in Sight?

Volume 58, Issue 1, Pages (July 2010)

John P. Mulhall, Francesco Montorsi European Urology

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

Volume 52, Issue 1, Pages (July 2007)

Bladder Cancer: A Major Public Health Issue

Volume 51, Issue 1, Pages (January 2007)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 66, Issue 4, Pages (October 2014)

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 50, Issue 4, Pages (October 2006)

Volume 54, Issue 6, Pages (December 2008)

Volume 70, Issue 1, Pages (July 2016)

Volume 56, Issue 2, Pages (August 2009)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 50, Issue 3, Pages (September 2006)

Volume 70, Issue 1, Pages e27-e28 (July 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Leonard S. Marks, Jiaoti Huang European Urology

Volume 56, Issue 1, Pages (July 2009)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Reply to Taimur T. Shah, Graeme MacLennan, Rob Pickard, Samuel McClinton and Veeru Kasivisvanathan's Letter to the Editor re: Zhangqun Ye, Guohua Zeng,

Volume 68, Issue 6, Pages e134-e135 (December 2015)

Volume 64, Issue 6, Pages (December 2013)

Volume 70, Issue 3, Pages e72-e74 (September 2016)

TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential Liang Cheng, Rodolfo Montironi,

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

Re: Christine McKillop

2005 Update on Pathology of Prostate Biopsies with Cancer

Volume 55, Issue 3, Pages (March 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 2, Pages (February 2013)

Volume 54, Issue 4, Pages (October 2008)

European Urology is “Your” Journal

The Start-Up of the Platinum Journal: A Fascinating Challenge

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Profile of Silodosin European Urology Supplements

Volume 53, Issue 6, Pages (June 2008)

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Volume 53, Issue 2, Pages (February 2008)

Bertrand Tombal, Richard Berges

Pathological Findings in TRUS Prostatic Biopsy—Diagnostic, Prognostic and Therapeutic Importance Rodolfo Montironi, Roberta Mazzucchelli, Vincenzo Scattoni,

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 51, Issue 5, Pages (May 2007)

2005 Update on Pathology of Prostate Biopsies with Cancer

Presentation transcript:

Volume 59, Issue 3, Pages e7-e8 (March 2011) Reply to Kiril Trpkov, Asli Yilmaz’ Letter to the Editor re: Rodolfo Montironi, Liang Cheng, Antonio Lopez-Beltran, et al. Original Gleason System Versus 2005 ISUP Modified Gleason System: The Importance of Indicating Which System Is Used in the Patient’s Pathology and Clinical Reports. Eur Urol 2010;58:369–73 Rodolfo Montironi, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Roberta Mazzucchelli, Gregor Mikuz, Ziya Kirkali, Francesco Montorsi European Urology Volume 59, Issue 3, Pages e7-e8 (March 2011) DOI: 10.1016/j.eururo.2010.11.028 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 (A) Prostate adenocarcinoma, Gleason pattern 3 (insert: normal prostate); (B) prostate adenocarcinoma with cribriform pattern; (C) prostate adenocarcinoma with glomeruloid pattern; (D) prostate adenocarcinoma Gleason pattern 5. European Urology 2011 59, e7-e8DOI: (10.1016/j.eururo.2010.11.028) Copyright © 2010 European Association of Urology Terms and Conditions